Morgan Stanley Upgrades ResMed (RMD) to Overweight
Tweet
Share
E-mailGet Alerts RMD Hot Sheet
Price: $215.19 --0%
Rating Summary:
11 Buy, 12 Hold, 2 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 9 | Down: 18 | New: 19
Rating Summary:
11 Buy, 12 Hold, 2 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 9 | Down: 18 | New: 19
Join SI Premium – FREE
Morgan Stanley upgraded ResMed (NYSE: RMD) from Equalweight to Overweight.
For an analyst ratings summary and ratings history on ResMed click here. For more ratings news on ResMed click here.
Shares of ResMed closed at $56.12 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Deutsche Bank Upgrades Palantir (PLTR) to Buy, 'risk/reward skews favorably'
- Jefferies Upgrades Lasertec Corp. (6920:JP) (LSRCF) to Buy
- Wolfe Research Upgrades Madrigal Pharmaceuticals (MDGL) to Outperform
Create E-mail Alert Related Categories
Hot Upgrades, UpgradesRelated Entities
Morgan StanleySign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
